Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.
Yu Y, Cai X, Wang G, Kong N, Liu Y, Xiao Y, Zhang C, Mu Y, Xiao S, Zhao Q, Wang C, Zhang G, Hiscox JA, Zhou EM.
Yu Y, et al. Among authors: xiao y, xiao s.
BMC Vet Res. 2014 Feb 8;10:39. doi: 10.1186/1746-6148-10-39.
BMC Vet Res. 2014.
PMID: 24507659
Free PMC article.
Clinical Trial.